Global Clinical Trial Imaging Market : Global Industry Analysis and Forecast (2018-2026) _ by Product & Services, Imaging Modality, End User, and Geography.

Global Clinical Trial Imaging Market : Global Industry Analysis and Forecast (2018-2026) _ by Product & Services, Imaging Modality, End User, and Geography.

Market Scenario

Global Clinical Trial Imaging Market is expected to reach USD1476.12 Million by 2026 from USD879.95 Million in 2018 at CAGR of 6.68% during forecast period. Key factors powering market growth are the raising number of contract research organizations, development in the pharmaceutical & biotechnology industries, and growing in R&D expenditure are the important drivers for the growth of the clinical trial imaging market. However, the high implementation cost of imaging systems is limiting the growth of clinical trial imaging market. Global clinical trial imaging market is segmented by product & services, imaging modality, end user, and geography. Imaging Modality is segmented by magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound, and others. Computed Tomography segment is expected to register the highest growth in the forecast period. High advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body are expected to drive computed tomography market growth. Based on Product & Services Market is segmented into software & services. Services sub-segment is estimated to hold the largest market share in the forecast period. The high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers will result into the increasing share of services segment market. Global Clinical Trial Imaging Market APAC is going to emerge as one of the higher growth regions during forecast period followed by North America and Europe owing to increasing development in pharmaceutical & biotechnology industries and raising R&D spending in the region will fuel the global clinical trial imaging market in APAC region.

Scope:

Global Clinical Trial Imaging Market by Product & Services:

• Software • Services

Global Clinical Trial Imaging Market by Imaging Modality:

• Magnetic Resonance Imaging (MRI) • Computed Tomography (CT) • Positron Emission Tomography (PET) • Ultrasound • X-Rays • Echocardiography • Other Imaging Modalities

Global Clinical Trial Imaging Market by End User:

• Pharmaceutical Companies • Biotechnology Companies • Medical Device Manufacturers • Contract Research Organizations • Academic and Government Research Institutes • Other End Users (Cosmetics & skin care industries)

Global Clinical Trial Imaging Market by Region:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America.

Key Players analyzed in the global clinical trial imaging market:

• Worldcare Clinical, LLC • Radiant Sage LLC • Ixico PLC • Intrinsic Imaging LLC • Cardiovascular Imaging Technologies, LLC • Biotelemetry, Inc. • Biomedical Systems Corporation • Icon PLC • Parexel International Corporation • Bioclinica, Inc. Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.   Global Practice Management System Market : Global industry Analysis and Forecast 2024

Table of Contents

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Clinical Trial Imaging Market Size, by Market Value (USDMn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Clinical Trial Imaging Market Analysis and Forecast 5.1. Global Clinical Trial Imaging Market Analysis and Forecast 5.2. Global Clinical Trial Imaging Market Size & Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Clinical Trial Imaging Market Analysis and Forecast, by Product & Services 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Clinical Trial Imaging Market Value Share Analysis, by Product & Services 6.4. Global Clinical Trial Imaging Market Size (USDMn) Forecast, by Product & Services 6.5. 6.4. Global Clinical Trial Imaging Market Analysis, by Product & Services 6.6. Global Clinical Trial Imaging Market Attractiveness Analysis, by Product & Services 7. Global Clinical Trial Imaging Market Analysis and Forecast, by Imaging Modality 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Clinical Trial Imaging Market Value Share Analysis, by Imaging Modality 7.4. Global Clinical Trial Imaging Market Size (USDMn) Forecast, by Imaging Modality 7.5. Global Clinical Trial Imaging Market Analysis, by Imaging Modality 7.6. Global Clinical Trial Imaging Market Attractiveness Analysis, by Imaging Modality 8. Global Clinical Trial Imaging Market Analysis, by Region 8.1. Key Findings 8.2. Global Clinical Trial Imaging Market Value Share Analysis, by Region 8.3. Global Clinical Trial Imaging Market Size (USDMn) Forecast, by Region 8.4. Global Clinical Trial Imaging Market Analysis, by Region 8.5. Global Clinical Trial Imaging Market Attractiveness Analysis, by Region 9. North America Clinical Trial Imaging Market Analysis 9.1. North America Clinical Trial Imaging Market Overview 9.2. North America Clinical Trial Imaging Market Value Share Analysis, by Product & Services 9.3. North America Clinical Trial Imaging Market Forecast, by Product & Services 9.3.1. Software 9.3.2. Services 9.4. North America Clinical Trial Imaging Market Value Share Analysis, by Imaging Modality 9.5. North America Clinical Trial Imaging Market Forecast, by Imaging Modality 9.5.1. Magnetic Resonance Imaging (MRI) 9.5.2. Computed Tomography (CT) 9.5.3. Positron Emission Tomography (PET) 9.5.4. Ultrasound 9.5.5. X-Rays 9.5.6. Echocardiography 9.5.7. Other Imaging Modalities 9.6. North America Clinical Trial Imaging Market Value Share Analysis, by End User 9.7. North America Clinical Trial Imaging Market Forecast, by End User 9.7.1. Pharmaceutical Companies 9.7.2. Biotechnology Companies 9.7.3. Medical Device Manufacturers 9.7.4. Contract Research Organizations 9.7.5. Academic and Government Research Institutes 9.7.6. Other End Users (Cosmetics & skin care industries) 9.8. North America Clinical Trial Imaging Market Value Share Analysis, by Country 9.9. North America Clinical Trial Imaging Market Forecast, by Country 9.9.1.1. U.S. 9.9.1.2. Canada. 9.10. U.S. Clinical Trial Imaging Market Forecast, by Product & Services 9.10.1. Software 9.10.2. Services 9.11. U.S. Clinical Trial Imaging Market Forecast, by Imaging Modality 9.11.1. Magnetic Resonance Imaging (MRI) 9.11.2. Computed Tomography (CT) 9.11.3. Positron Emission Tomography (PET) 9.11.4. Ultrasound 9.11.5. X-Rays 9.11.6. Echocardiography 9.11.7. Other Imaging Modalities 11.1 U.S. Clinical Trial Imaging Market Forecast, by End User 11.1.1 Pharmaceutical Companies 11.1.2 Biotechnology Companies 11.1.3 Medical Device Manufacturers 11.1.4 Contract Research Organizations 11.1.5 Academic and Government Research Institutes 11.1.6 Other End Users (Cosmetics & skin care industries) 11.2 Canada Clinical Trial Imaging Market Forecast, by Product & Services 11.2.1 Software 11.2.2 Services 11.3 Canada Clinical Trial Imaging Market Forecast, by Imaging Modality 11.3.1 Magnetic Resonance Imaging (MRI) 11.3.2 Computed Tomography (CT) 11.3.3 Positron Emission Tomography (PET) 11.3.4 Ultrasound 11.3.5 X-Rays 11.3.6 Echocardiography 11.3.7 Other Imaging Modalities 11.4 Canada Clinical Trial Imaging Market Forecast, by End User 11.4.1 Pharmaceutical Companies 11.4.2 Biotechnology Companies 11.4.3 Medical Device Manufacturers 11.4.4 Contract Research Organizations 11.4.5 Academic and Government Research Institutes 11.4.6 Other End Users (Cosmetics & skin care industries) 11.5 North America Clinical Trial Imaging Market Attractiveness Analysis 11.5.1 By Product & Services 11.5.2 By Imaging Modality 11.5.3 By End User 11.6 PEST Analysis 12 Europe Clinical Trial Imaging Market Analysis 12.1 Key Findings 12.2 Europe Clinical Trial Imaging Market Overview 12.3 Europe Clinical Trial Imaging Market Value Share Analysis, by Product & Services 12.4 Europe Clinical Trial Imaging Market Forecast, by Imaging Modality 12.4.1 Egg 12.4.2 Soy 12.4.3 Sunflower 12.4.4 Others 12.5 Europe Clinical Trial Imaging Market Value Share Analysis, by Imaging Modality 12.6 Europe Clinical Trial Imaging Market Forecast, by Imaging Modality 12.6.1 Magnetic Resonance Imaging (MRI) 12.6.2 Computed Tomography (CT) 12.6.3 Positron Emission Tomography (PET) 12.6.4 Ultrasound 12.6.5 X-Rays 12.6.6 Echocardiography 12.6.7 Other Imaging Modalities 12.7 Europe Clinical Trial Imaging Market Forecast, by End User 12.7.1 Pharmaceutical Companies 12.7.2 Biotechnology Companies 12.7.3 Medical Device Manufacturers 12.7.4 Contract Research Organizations 12.7.5 Academic and Government Research Institutes 12.7.6 Other End Users (Cosmetics & skin care industries) 12.8 Europe Clinical Trial Imaging Market Forecast, by Country 12.8.1 Germany 12.8.2 U.K. 12.8.3 France 12.8.4 Italy 12.8.5 Spain 12.8.6 Rest of Europe 12.9 Europe Clinical Trial Imaging Market Analysis, by Country/ Sub-region 12.10 Germany Clinical Trial Imaging Market Forecast, by Product & Services 12.10.1 Software 12.10.2 Services 12.11 Germany Clinical Trial Imaging Market Forecast, by Imaging Modality 12.11.1 Magnetic Resonance Imaging (MRI) 12.11.2 Computed Tomography (CT) 12.11.3 Positron Emission Tomography (PET) 12.11.4 Ultrasound 12.11.5 X-Rays 12.11.6 Echocardiography 12.11.7 Other Imaging Modalities 12.12 Germany Clinical Trial Imaging Market Forecast, by End User 12.12.1 Pharmaceutical Companies 12.12.2 Biotechnology Companies 12.12.3 Medical Device Manufacturers 12.12.4 Contract Research Organizations 12.12.5 Academic and Government Research Institutes 12.12.6 Other End Users (Cosmetics & skin care industries) 12.13 U.K. Clinical Trial Imaging Market Forecast, by Product & Services 12.13.1 Software 12.13.2 Services 12.14 U.K. Clinical Trial Imaging Market Forecast, by Imaging Modality 12.14.1 Magnetic Resonance Imaging (MRI) 12.14.2 Computed Tomography (CT) 12.14.3 Positron Emission Tomography (PET) 12.14.4 Ultrasound 12.14.5 X-Rays 12.14.6 Echocardiography 12.14.7 Other Imaging Modalities 12.15 Germany Clinical Trial Imaging Market Forecast, by End User 12.15.1 Pharmaceutical Companies 12.15.2 Biotechnology Companies 12.15.3 Medical Device Manufacturers 12.15.4 Contract Research Organizations 12.15.5 Academic and Government Research Institutes 12.15.6 Other End Users (Cosmetics & skin care industries) 12.16 France Clinical Trial Imaging Market Forecast, by Product & Services 12.16.1 Software 12.16.2 Services 12.17 France Clinical Trial Imaging Market Forecast, by Imaging Modality 12.17.1 Magnetic Resonance Imaging (MRI) 12.17.2 Computed Tomography (CT) 12.17.3 Positron Emission Tomography (PET) 12.17.4 Ultrasound 12.17.5 X-Rays 12.17.6 Echocardiography 12.17.7 Other Imaging Modalities 12.18 Italy Clinical Trial Imaging Market Forecast, by Product & Services 12.18.1 Egg 12.18.2 Soy 12.18.3 Sunflower 12.18.4 Others 12.19 Italy Clinical Trial Imaging Market Forecast, by Imaging Modality 12.19.1 Food 12.19.2 Feed 12.19.3 Nutrition & Supplements 12.19.4 Pharmaceutical 12.19.5 Other 12.20 Italy Clinical Trial Imaging Market Forecast, by End User 12.20.1 Pharmaceutical Companies 12.20.2 Biotechnology Companies 12.20.3 Medical Device Manufacturers 12.20.4 Contract Research Organizations 12.20.5 Academic and Government Research Institutes 12.20.6 Other End Users (Cosmetics & skin care industries) 12.21 Spain Clinical Trial Imaging Market Forecast, by Product & Services 12.21.1 Software 12.21.2 Services 12.22 Spain Clinical Trial Imaging Market Forecast, by Imaging Modality 12.22.1 Magnetic Resonance Imaging (MRI) 12.22.2 Computed Tomography (CT) 12.22.3 Positron Emission Tomography (PET) 12.22.4 Ultrasound 12.22.5 X-Rays 12.22.6 Echocardiography 12.22.7 Other Imaging Modalities 12.23 Spain Clinical Trial Imaging Market Forecast, by End User 12.23.1 Pharmaceutical Companies 12.23.2 Biotechnology Companies 12.23.3 Medical Device Manufacturers 12.23.4 Contract Research Organizations 12.23.5 Academic and Government Research Institutes 12.23.6 Other End Users (Cosmetics & skin care industries) 12.24 Rest of Europe Clinical Trial Imaging Market Forecast, by Product & Services 12.24.1 Software 12.24.2 Services 12.25 Rest of Europe Clinical Trial Imaging Market Forecast, by Imaging Modality 12.25.1 Magnetic Resonance Imaging (MRI) 12.25.2 Computed Tomography (CT) 12.25.3 Positron Emission Tomography (PET) 12.25.4 Ultrasound 12.25.5 X-Rays 12.25.6 Echocardiography 12.25.7 Other Imaging Modalities 12.26 Europe Clinical Trial Imaging Market Attractiveness Analysis 12.26.1 By Product & Services 12.26.2 By Imaging Modality 12.26.3 By End User 12.27 PEST Analysis 13 Asia Pacific Clinical Trial Imaging Market Analysis 13.1 Key Findings 13.2 Asia Pacific Clinical Trial Imaging Market Overview 13.3 Asia Pacific Clinical Trial Imaging Market Value Share Analysis, by Product & Services 13.3.1 Software 13.3.2 Services 13.4 Asia Pacific Clinical Trial Imaging Market Forecast, by Imaging Modality 13.4.1 Magnetic Resonance Imaging (MRI) 13.4.2 Computed Tomography (CT) 13.4.3 Positron Emission Tomography (PET) 13.4.4 Ultrasound 13.4.5 X-Rays 13.4.6 Echocardiography 13.4.7 Other Imaging Modalities 13.5 Asia Pacific Clinical Trial Imaging Market Value Share Analysis, by End User 13.5.1 Pharmaceutical Companies 13.5.2 Biotechnology Companies 13.5.3 Medical Device Manufacturers 13.5.4 Contract Research Organizations 13.5.5 Academic and Government Research Institutes 13.5.6 Other End Users (Cosmetics & skin care industries) 13.6 Asia Pacific Clinical Trial Imaging Market Value Share Analysis, by Country 13.7 Asia Pacific Clinical Trial Imaging Market Forecast, by Country 13.7.1 China. 13.7.2 India. 13.7.3 Japan. 13.7.4 ASEAN. 13.7.5 Rest of Asia Pacific. 13.8 Asia Pacific Clinical Trial Imaging Market Analysis, by Country/ Sub-region 13.9 China Clinical Trial Imaging Market Forecast, by Product & Services 13.9.1 Software 13.9.2 Services 13.10 China Clinical Trial Imaging Market Forecast, by Imaging Modality 13.10.1 Magnetic Resonance Imaging (MRI) 13.10.2 Computed Tomography (CT) 13.10.3 Positron Emission Tomography (PET) 13.10.4 Ultrasound 13.10.5 X-Rays 13.10.6 Echocardiography 13.10.7 Other Imaging Modalities 13.11 China Clinical Trial Imaging Market Forecast, by End User 13.11.1 Pharmaceutical Companies 13.11.2 Biotechnology Companies 13.11.3 Medical Device Manufacturers 13.11.4 Contract Research Organizations 13.11.5 Academic and Government Research Institutes 13.11.6 Other End Users (Cosmetics & skin care industries) 13.12 India Clinical Trial Imaging Market Forecast, by Imaging Modality 13.12.1 Software 13.12.2 Services 13.13 India Clinical Trial Imaging Market Forecast, by Product & Services 13.13.1 Software 13.13.2 Services 13.14 India Clinical Trial Imaging Market Forecast, by End User 13.14.1 Pharmaceutical Companies 13.14.2 Biotechnology Companies 13.14.3 Medical Device Manufacturers 13.14.4 Contract Research Organizations 13.14.5 Academic and Government Research Institutes 13.14.6 Other End Users (Cosmetics & skin care industries) 13.15 ASEAN Clinical Trial Imaging Market Forecast, by Product & Services 13.15.1 Software 13.15.2 Services 13.16 ASEAN Clinical Trial Imaging Market Forecast, by Imaging Modality 13.16.1 Magnetic Resonance Imaging (MRI) 13.16.2 Computed Tomography (CT) 13.16.3 Positron Emission Tomography (PET) 13.16.4 Ultrasound 13.16.5 X-Rays 13.16.6 Echocardiography 13.16.7 Other Imaging Modalities 13.17 ASEAN Clinical Trial Imaging Market Forecast, by End User 13.17.1 Pharmaceutical Companies 13.17.2 Biotechnology Companies 13.17.3 Medical Device Manufacturers 13.17.4 Contract Research Organizations 13.17.5 Academic and Government Research Institutes 13.17.6 Other End Users (Cosmetics & skin care industries) 13.18 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, by Product & Services 13.18.1 Software 13.18.2 Services 13.19 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, by Imaging Modality 13.19.1 Magnetic Resonance Imaging (MRI) 13.19.2 Computed Tomography (CT) 13.19.3 Positron Emission Tomography (PET) 13.19.4 Ultrasound 13.19.5 X-Rays 13.19.6 Echocardiography 13.19.7 Other Imaging Modalities 13.20 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, by End User 13.20.1 Pharmaceutical Companies 13.20.2 Biotechnology Companies 13.20.3 Medical Device Manufacturers 13.20.4 Contract Research Organizations 13.20.5 Academic and Government Research Institutes 13.20.6 Other End Users (Cosmetics & skin care industries) 13.21 Asia Pacific Clinical Trial Imaging Market Attractiveness Analysis 13.21.1 By Product & Services 13.21.2 By Imaging Modality 13.21.3 End User 13.22 PEST Analysis 14 Middle East & Africa Clinical Trial Imaging Market Analysis 14.1 Key Findings 14.2 Middle East & Africa Clinical Trial Imaging Market Overview 14.3 Middle East & Africa Clinical Trial Imaging Market Value Share Analysis, by Product & Services 14.4 Middle East & Africa Clinical Trial Imaging Market Forecast, by Product & Services 14.4.1 Software 14.4.2 Services 14.5 Middle East & Africa Clinical Trial Imaging Market Value Share Analysis, by Imaging Modality 14.6 Middle East & Africa Clinical Trial Imaging Market Forecast, by Imaging Modality 14.6.1 Magnetic Resonance Imaging (MRI) 14.6.2 Computed Tomography (CT) 14.6.3 Positron Emission Tomography (PET) 14.6.4 Ultrasound 14.6.5 X-Rays 14.6.6 Echocardiography 14.6.7 Other Imaging Modalities 14.7 Middle East & Africa Clinical Trial Imaging Market Value Share Analysis, by End User 14.8 Middle East & Africa Clinical Trial Imaging Market Forecast, by End User 14.8.1 Pharmaceutical Companies 14.8.2 Biotechnology Companies 14.8.3 Medical Device Manufacturers 14.8.4 Contract Research Organizations 14.8.5 Academic and Government Research Institutes 14.8.6 Other End Users (Cosmetics & skin care industries) 14.9 Middle East & Africa Clinical Trial Imaging Market Value Share Analysis, by Country 14.10 Middle East & Africa Clinical Trial Imaging Market Forecast, by Country 14.10.1 GCC. 14.10.2 South Africa. 14.10.3 Rest of Middle East & Africa. 14.11 Middle East & Africa Clinical Trial Imaging Market Analysis, by Country/ Sub-region 14.12 GCC Clinical Trial Imaging Market Forecast, by Product & Services 14.12.1 Software 14.12.2 Services 14.13 GCC Clinical Trial Imaging Market Forecast, by Imaging Modality 14.13.1 Magnetic Resonance Imaging (MRI) 14.13.2 Computed Tomography (CT) 14.13.3 Positron Emission Tomography (PET) 14.13.4 Ultrasound 14.13.5 X-Rays 14.13.6 Echocardiography 14.13.7 Other Imaging Modalities 14.14 GCC Clinical Trial Imaging Market Forecast, by End User 14.14.1 Pharmaceutical Companies 14.14.2 Biotechnology Companies 14.14.3 Medical Device Manufacturers 14.14.4 Contract Research Organizations 14.14.5 Academic and Government Research Institutes 14.14.6 Other End Users (Cosmetics & skin care industries) 14.15 South Africa Clinical Trial Imaging Market Forecast, by Product & Services 14.15.1 Software 14.15.2 Services 14.16 South Africa Clinical Trial Imaging Market Forecast, by Imaging Modality 14.16.1 Magnetic Resonance Imaging (MRI) 14.16.2 Computed Tomography (CT) 14.16.3 Positron Emission Tomography (PET) 14.16.4 Ultrasound 14.16.5 X-Rays 14.16.6 Echocardiography 14.16.7 Other Imaging Modalities 14.17 South Africa Clinical Trial Imaging Market Forecast, by End User 14.17.1 Pharmaceutical Companies 14.17.2 Biotechnology Companies 14.17.3 Medical Device Manufacturers 14.17.4 Contract Research Organizations 14.17.5 Academic and Government Research Institutes 14.17.6 Other End Users (Cosmetics & skin care industries) 14.18 Rest of Middle East & Africa Clinical Trial Imaging Market Forecast, by Product & Services 14.18.1 Software 14.18.2 Services 14.19 Rest of Middle East & Africa Clinical Trial Imaging Market Forecast, by Imaging Modality 14.19.1 Magnetic Resonance Imaging (MRI) 14.19.2 Computed Tomography (CT) 14.19.3 Positron Emission Tomography (PET) 14.19.4 Ultrasound 14.19.5 X-Rays 14.19.6 Echocardiography 14.19.7 Other Imaging Modalities 14.20 Rest of Middle East & Africa Clinical Trial Imaging Market Forecast, by End User 14.20.1 Pharmaceutical Companies 14.20.2 Biotechnology Companies 14.20.3 Medical Device Manufacturers 14.20.4 Contract Research Organizations 14.20.5 Academic and Government Research Institutes 14.20.6 Other End Users (Cosmetics & skin care industries) 14.21 Middle East & Africa Clinical Trial Imaging Market Attractiveness Analysis 14.21.1 By Product & Services 14.21.2 By Application type 14.21.3 By End User 14.22 PEST Analysis 15 Latin America Clinical Trial Imaging Market Analysis 15.1 Key Findings 15.2 Latin America Clinical Trial Imaging Market Overview 15.3 Latin America Clinical Trial Imaging Market Value Share Analysis, by Product & Services 15.4 Latin America Clinical Trial Imaging Market Forecast, by Product & Services 15.4.1 Software 15.4.2 Services 15.5 Latin America Clinical Trial Imaging Market Value Share Analysis, by Country 15.6 Latin America Clinical Trial Imaging Market Forecast, by Country 15.6.1.1 Brazil. 15.6.1.2 Mexico. 15.6.1.3 Rest of Latin America. 15.7 Latin America Clinical Trial Imaging Market Analysis, by Country/ Sub-region 15.8 Brazil Clinical Trial Imaging Market Forecast, by Product & Services 15.8.1 Software 15.8.2 Services 15.9 Brazil Clinical Trial Imaging Market Forecast, by Imaging Modality 15.9.1 Magnetic Resonance Imaging (MRI) 15.9.2 Computed Tomography (CT) 15.9.3 Positron Emission Tomography (PET) 15.9.4 Ultrasound 15.9.5 X-Rays 15.9.6 Echocardiography 15.9.7 Other Imaging Modalities 15.10 Brazil Clinical Trial Imaging Market Forecast, by End User 15.10.1 Pharmaceutical Companies 15.10.2 Biotechnology Companies 15.10.3 Medical Device Manufacturers 15.10.4 Contract Research Organizations 15.10.5 Academic and Government Research Institutes 15.10.6 Other End Users (Cosmetics & skin care industries) 15.11 Mexico Clinical Trial Imaging Market Forecast, by Product & Services 15.11.1 Software 15.11.2 Services 15.12 Mexico Clinical Trial Imaging Market Forecast, by Imaging Modality 15.12.1 Magnetic Resonance Imaging (MRI) 15.12.2 Computed Tomography (CT) 15.12.3 Positron Emission Tomography (PET) 15.12.4 Ultrasound 15.12.5 X-Rays 15.12.6 Echocardiography 15.12.7 Other Imaging Modalities 15.13 Mexico Clinical Trial Imaging Market Forecast, by End User 15.13.1 Pharmaceutical Companies 15.13.2 Biotechnology Companies 15.13.3 Medical Device Manufacturers 15.13.4 Contract Research Organizations 15.13.5 Academic and Government Research Institutes 15.13.6 Other End Users (Cosmetics & skin care industries) 15.14 Rest of Latin America Clinical Trial Imaging Market Forecast, by Product & Services 15.14.1 Software 15.14.2 Services 15.15 Latin America Clinical Trial Imaging Market Attractiveness Analysis 15.15.1 By Product & Services 15.15.2 By Application type 15.15.3 By End User 15.16 PEST Analysis 16 Company Profiles 16.1 Market Share Analysis, by Company 16.2 Competition Matrix 16.3 Company Profiles: Key Player 16.4 Company Overview 16.5 Archer Daniels Midland Company 16.5.1 Financial Overview 16.5.2 Business Strategy 16.5.3 Recent Developments 16.5.4 Manufacturing Footprint 16.6 Worldcare Clinical, LLC 16.7 Radiant Sage LLC 16.8 Ixico PLC 16.9 Intrinsic Imaging LLC 16.10 Cardiovascular Imaging Technologies, LLC 16.11 Biotelemetry, Inc. 16.12 Biomedical Systems Corporation 16.13 Icon PLC 16.14 Parexel International Corporation 16.15 Bioclinica, Inc. 17 Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID6603
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now